
Biomedical and ICT Convergence Market Outlook and Forecasts 2022 – 2030
Description
Biomedical and ICT Convergence Market Outlook and Forecasts 2022 – 2030
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices.
In addition to forecasts for IoT connected healthcare devices (standalone, wearable, and implantable), the report also assesses the outlook from 2022 to 2030 for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
Select Report Findings:
The biomedical ICT market is expected to exceed $86 billion USD by 2030
North America will lead the biomedical ICT market during forecasted period
The hardware technology will represent over 50% of the biomedical ICT market
Diagnostic and research will be the prime application area within biomedical ICT market
Biomedical and ICT convergence is the foundation for the preponderance of biomedical tech
The field of biomedicine is concerned with the application of various natural science disciplines for the development of knowledge, interventions, and/or technologies for use in healthcare. The Information and Communications Technology sector focuses on telecommunications, computing, and the integration of both. Related to ICT is the term TMT, which more broadly refers to Technology, Media, and Telecom. Both are related to the use of various digital technologies for communications, applications, commerce, and content. The convergence of biomedical and ICT represents a high opportunity area for both healthcare and ICT industries.
In addition to seeking cures to disease and ailment prevention, the convergence of biomedical and ICT technologies and solutions will lead to improved treatment efficacy as well as overall improvements in healthcare service delivery efficiency and effectiveness. With healthcare costs growing much faster than the general inflation rate, it is of the utmost importance to simultaneously seek improved treatment while continuously driving down business costs. These costs include ongoing operational expenditures as well as expensive R&D such as drug discovery and other pharmaceutical related areas such as vaccine development that takes into account precision medicine practices.
Various ICT tools may be employed such as IoT enabled monitoring to determine the effectiveness of medical procedures, which can be especially important when administering new and unproven healthcare modalities. One specific example is the administration of vaccines, which is believed to potentially cause harm to a subset of the population based on epigenetics, which is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. This is believed to be an area in which a healthcare modality (in this example, vaccines) is designed with one intent (to inoculate one to prevent the onset of disease), but may actually trigger unintended consequences such as causing harm based on an individual’s unique gene expression.
One of the fastest growing areas for ICT in healthcare is the use of wireless access by IP-enabled, handheld digital devices. Wearables and implantable technology hold the promise of a level of monitoring and healthcare administration that is unprecedented in the history of health science. Ranging from treatment administration to clinical decision support, connected devices are a rapidly evolving tool for the advancement of healthcare practices.
These same tools may be used for both reactive and proactive medical modalities such as insulin modification and vaccine optimization respectively. The convergence of ICT and biomedicine is therefore anticipated to lead to both improved economics (lower costs and improved revenues through identification of new healthcare treatments) as well as improve overall public health.
Companies in Report:
Abbott Laboratories
ActiveLinxx LLC
Agfa Healthcare
Amgen Inc.
Analog Devices
AstraZeneca
Bio Rad Laboratories
Biodirection (NanoDX)
Biogen
BioTelemetry (Philips Company)
Carpenter Technology (CRS Holdings)
Celgene Corporation
Dentsply Sirona
Drager
First Sensor
Fresenius Medical Care
GE Healthcare
Getinge AB
Gilead Sciences
Haier Biomedical
Helmer Scientific
Hoffman-La Roche Ltd.
Honeywell
Jafron Biomedical Co Ltd
Johnson & Johnson Services
KLS Martin Group
Lifesense Group B.V.
Lonza Group
Medtronic
Merck & Co
Nonin Medical
Novartis AG
Novo Nordisk
NXP Semiconductor
Olympus Corporation
Panasonic
Pfizer Inc.
Philips Healthcare
Samsung Healthcare
Sanofi Aventis
Siemens Healthineers
Skanray Technologies
Smiths Medical Inc.
STMicroelectronics
Stryker
TE Connectivity
Texas Instruments
Thermo Fisher
Wright Medical Group
Zimmer Biomet
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices.
In addition to forecasts for IoT connected healthcare devices (standalone, wearable, and implantable), the report also assesses the outlook from 2022 to 2030 for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
Select Report Findings:
The biomedical ICT market is expected to exceed $86 billion USD by 2030
North America will lead the biomedical ICT market during forecasted period
The hardware technology will represent over 50% of the biomedical ICT market
Diagnostic and research will be the prime application area within biomedical ICT market
Biomedical and ICT convergence is the foundation for the preponderance of biomedical tech
The field of biomedicine is concerned with the application of various natural science disciplines for the development of knowledge, interventions, and/or technologies for use in healthcare. The Information and Communications Technology sector focuses on telecommunications, computing, and the integration of both. Related to ICT is the term TMT, which more broadly refers to Technology, Media, and Telecom. Both are related to the use of various digital technologies for communications, applications, commerce, and content. The convergence of biomedical and ICT represents a high opportunity area for both healthcare and ICT industries.
In addition to seeking cures to disease and ailment prevention, the convergence of biomedical and ICT technologies and solutions will lead to improved treatment efficacy as well as overall improvements in healthcare service delivery efficiency and effectiveness. With healthcare costs growing much faster than the general inflation rate, it is of the utmost importance to simultaneously seek improved treatment while continuously driving down business costs. These costs include ongoing operational expenditures as well as expensive R&D such as drug discovery and other pharmaceutical related areas such as vaccine development that takes into account precision medicine practices.
Various ICT tools may be employed such as IoT enabled monitoring to determine the effectiveness of medical procedures, which can be especially important when administering new and unproven healthcare modalities. One specific example is the administration of vaccines, which is believed to potentially cause harm to a subset of the population based on epigenetics, which is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. This is believed to be an area in which a healthcare modality (in this example, vaccines) is designed with one intent (to inoculate one to prevent the onset of disease), but may actually trigger unintended consequences such as causing harm based on an individual’s unique gene expression.
One of the fastest growing areas for ICT in healthcare is the use of wireless access by IP-enabled, handheld digital devices. Wearables and implantable technology hold the promise of a level of monitoring and healthcare administration that is unprecedented in the history of health science. Ranging from treatment administration to clinical decision support, connected devices are a rapidly evolving tool for the advancement of healthcare practices.
These same tools may be used for both reactive and proactive medical modalities such as insulin modification and vaccine optimization respectively. The convergence of ICT and biomedicine is therefore anticipated to lead to both improved economics (lower costs and improved revenues through identification of new healthcare treatments) as well as improve overall public health.
Companies in Report:
Abbott Laboratories
ActiveLinxx LLC
Agfa Healthcare
Amgen Inc.
Analog Devices
AstraZeneca
Bio Rad Laboratories
Biodirection (NanoDX)
Biogen
BioTelemetry (Philips Company)
Carpenter Technology (CRS Holdings)
Celgene Corporation
Dentsply Sirona
Drager
First Sensor
Fresenius Medical Care
GE Healthcare
Getinge AB
Gilead Sciences
Haier Biomedical
Helmer Scientific
Hoffman-La Roche Ltd.
Honeywell
Jafron Biomedical Co Ltd
Johnson & Johnson Services
KLS Martin Group
Lifesense Group B.V.
Lonza Group
Medtronic
Merck & Co
Nonin Medical
Novartis AG
Novo Nordisk
NXP Semiconductor
Olympus Corporation
Panasonic
Pfizer Inc.
Philips Healthcare
Samsung Healthcare
Sanofi Aventis
Siemens Healthineers
Skanray Technologies
Smiths Medical Inc.
STMicroelectronics
Stryker
TE Connectivity
Texas Instruments
Thermo Fisher
Wright Medical Group
Zimmer Biomet
Table of Contents
161 Pages
- 1.0 Executive Summary
- 1.1 Overview
- 1.2 Research Objectives
- 1.3 Select Findings
- 2.0 Introduction
- 2.1 Biomedical Technology
- 2.1.1 Biomedical Science
- 2.1.2 Biomedical Engineering
- 2.1.3 Biomedical Informatics
- 2.1.4 Biomedical Research and Development
- 2.2 Biomedical and ICT Convergence
- 2.3 Biotechnology vs. Biomedical Technology
- 2.4 Biomedicine
- 2.5 Market Trends
- 3.0 Biomedical and ICT Technologies and Solutions
- 3.1 Technology Analysis
- 3.1.1 Biomedical Diagnostics Devices
- 3.1.1.1 Electrochemical Test Strips
- 3.1.1.2 Integrated Cartridges
- 3.1.1.3 Lateral Flow Assays
- 3.1.1.4 Molecular Diagnostics
- 3.1.2 Bionanotechnology
- 3.1.3 Temperature Sensors
- 3.1.4 Refrigerators and Freezers
- 3.1.5 Metal Equipment
- 3.1.6 Software Technology and ICT Services
- 3.2 Biomedical and ICT Application Analysis
- 3.2.1 Diagnostics and Research Solution
- 3.2.2 Tissue Engineering and Regeneration
- 3.2.3 Fermentation
- 3.2.4 Cell Based Assay
- 3.2.5 PCR Technology
- 3.2.6 Chromatography
- 3.2.7 Additive Metal Solution
- 3.3 Cloning and Somatic Cell Nuclear Transfer
- 3.4 Industry Specific Uses
- 3.4.1 Medical, Pharmaceutical, and Health
- 3.4.2 Food and Agriculture
- 3.4.3 Natural Resources and Environment
- 3.4.4 Industrial Processing
- 3.4.5 Bioinformatics
- 3.5 Cloud Deployment and IT Infrastructure Management
- 4.0 Company Analysis
- 4.1 Abbott Laboratories
- 4.2 Amgen Inc.
- 4.3 Analog Devices
- 4.4 AstraZeneca
- 4.5 Biogen
- 4.6 Bio Rad Laboratories
- 4.7 Biodirection (NanoDX)
- 4.8 BioTelemetry (Philips Company)
- 4.9 Carpenter Technology (CRS Holdings)
- 4.10 Celgene Corporation
- 4.11 Dentsply Sirona
- 4.12 First Sensor
- 4.13 GE Healthcare
- 4.14 Gilead Sciences
- 4.15 Haier Biomedical
- 4.16 Helmer Scientific
- 4.17 Hoffman-La Roche Ltd.
- 4.18 Honeywell
- 4.19 Johnson & Johnson Services
- 4.20 Lonza Group
- 4.21 Medtronic
- 4.22 Merck & Co
- 4.23 Nonin Medical
- 4.24 Novartis AG
- 4.25 Novo Nordisk
- 4.26 NXP Semiconductor
- 4.27 Panasonic
- 4.28 Pfizer Inc.
- 4.29 Sanofi Aventis
- 4.30 Smiths Medical Inc.
- 4.31 STMicroelectronics
- 4.32 TE Connectivity
- 4.33 Texas Instruments
- 4.34 Thermo Fisher
- 4.35 Wright Medical Group
- 4.36 Zimmer Biomet
- 4.37 Lifesense Group B.V.
- 4.38 ActiveLinxx LLC
- 4.39 Samsung Healthcare
- 4.40 Agfa Healthcare
- 4.41 Drager
- 4.42 Fresenius Medical Care
- 4.43 KLS Martin Group
- 4.44 Getinge AB
- 4.45 Olympus Corporation
- 4.46 Philips Healthcare
- 4.47 Siemens Healthineers
- 4.48 Skanray Technologies
- 4.49 Stryker
- 4.50 Jafron Biomedical Co Ltd
- 5.0 Market Analysis and Forecast 2022 – 2030
- 5.1 Global Biomedical ICT Market 2022 – 2030
- 5.1.1 Global Biomedical ICT Market
- 5.1.2 Biomedical ICT Market by Technology
- 5.1.2.1 Biomedical ICT Market by Hardware
- 5.1.2.1.1 Biomedical ICT Market by Diagnostic Device
- 5.1.2.1.2 Biomedical ICT Market by Temperature Sensor
- 5.1.2.1.3 Biomedical ICT Market by Refrigerators and Freezers
- 5.1.2.1.4 Biomedical ICT Market by Metal Equipment
- 5.1.2.2 Biomedical ICT Market by Software
- 5.1.2.3 Biomedical ICT Market by Service
- 5.1.3 Biomedical ICT Market by Solution
- 5.1.3.1 Biomedical ICT Market by Diagnostics and Research Solution
- 5.1.3.2 Biomedical ICT Market by Biomedical Metal Solution
- 5.1.4 Biomedical ICT Market by Industry Vertical
- 5.1.5 Biomedical ICT Market by Cloud Deployment
- 5.2 Regional Biomedical ICT Market 2022 – 2030
- 5.2.1 Biomedical ICT Market by Region
- 5.2.2 North America Biomedical ICT Market: Hardware, Software, Service, Solution, Industry Vertical, Cloud Deployment, and Country
- 5.2.3 Europe Biomedical ICT Market: Hardware, Software, Service, Solution, Industry Vertical, Cloud Deployment, and Country
- 5.2.4 APAC Biomedical ICT Market: Hardware, Software, Service, Solution, Industry Vertical, Cloud Deployment, and Country
- 5.2.5 Latin America Biomedical ICT Market: Hardware, Software, Service, Solution, Industry Vertical, Cloud Deployment, and Country
- 5.2.6 MEA Biomedical ICT Market: Hardware, Software, Service, Solution, Industry Vertical, Cloud Deployment, and Country
- 6.0 Conclusions and Recommendations
- 6.1 Advertisers and Media Companies
- 6.2 Artificial Intelligence Providers
- 6.3 Biomedical Device and Equipment Providers
- 6.4 Broadband Infrastructure Providers
- 6.5 Communication Service Providers
- 6.6 Computing Companies
- 6.7 Data Analytics Providers
- 6.8 Contract Research Organizations
- 6.9 Networking Equipment Providers
- 6.10 Networking Security Providers
- 6.11 Semiconductor Companies
- 6.12 IoT Suppliers and Service Providers
- 6.13 Software Providers
- 6.14 Pharmaceuticals and Hospitals
- 6.15 Enterprise and Government
- 7.0 Appendix: Connected Medical Device Market Analysis and Forecasts
- 7.1 Connected Medical Device Market Drivers
- 7.1.1 Connected Health and Telemedicine
- 7.1.2 Wearable Healthcare Devices
- 7.1.3 Specialized Healthcare Devices
- 7.2 Global Connected Medical Device Market
- 7.3 Connected Medical Device Market by Manufacturing Method
- 7.4 Connected Medical Device Market by Location/ Usage
- 7.5 Connected Medical Device Market by Delivery/Acquisition
- 7.6 Connected Medical Device Market by Risk Classification
- 7.7 Connected Medical Device Market by Industry Sub-sector
- 7.8 Connected Medical Device Market by Key Therapeutic Segments
- 7.9 Connected Medical Device Market by Connectivity Method
- 7.10 Connected Medical Device Markets by Region
- 7.10.1 North America Connected Medical Device Market
- 7.10.2 Europe Connected Medical Device Market
- 7.10.3 APAC Connected Medical Device Market
- 7.10.4 Latin America Connected Medical Device Market
- 7.10.5 Middle East and Africa Connected Medical Device Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.